Bonus shares: Listed here are three shares to commerce ex-bonus subsequent week. These embrace Beta Medicine Ltd, Dhanalaxmi Roto Spinners Ltd, and KBC International
Bonus Subject particulars
1.Beta Medicine Ltd bonus details- Beta Medicine, on 19 March had intimated the Nationwide Inventory Alternate (NSE) in regards to the forthcoming Board Assembly to be held. As per the intimation on the exchanges, the Small and Medium Enterprise (SME) firm Beta Pharma a gathering of the Board of Administrators has been scheduled to be held on Thursday, 27 th day of March, 2025 to transact the enterprise of contemplating and approving the allotment of 4,80,693 absolutely paid-up fairness shares of the Firm of face worth of ₹10 every, underneath the Bonus Subject
2. Dhanalaxmi Roto Spinners bonus particulars – The corporate on the had knowledgeable the exchanges in regards to the receipt of the approval of the difficulty of the bonus situation by shareholders on the Further Strange Normal Assembly held on 11 March, 2025 . The corporate additionally had knowledgeable in regards to the receipt of In-principal approval from BSE Restricted for situation and proposed allotment of 39,00,300 Bonus Fairness Shares of Rs. 10/- every within the ratio of 1(one) new fairness share for each (1) present fairness share held within the Firm.
Firm has mounted the “Report Date” as Wednesday, 26!” March, 2025 (T- Day) for the aim of ascertaining the eligibility of shareholders entitled for allotment of Bonus Fairness Shares.
3.KBC International Ltd- the Firm has mounted the ‘Report Date’ as Friday, March 28,2025 to find out eligible shareholders entitled to obtain the Bonus Shares.
KBC International has Beneficial issuance of absolutely paid up Bonus Share within the ratio of 1:1 i. e. 1(One) Fairness Share for each 1 (One) absolutely paid up Fairness Shares of Rs. 1/- every topic to approval of the shareholders of the Firm.
Disclaimer: The views and proposals given on this article are these of particular person analysts. These don’t signify the views of Mint. We advise traders to verify with licensed specialists earlier than making any funding selections.
